Research Unit of Genetic and Biologic Factors of Atherosclerosis

Monastir, Tunisia

Research Unit of Genetic and Biologic Factors of Atherosclerosis

Monastir, Tunisia
SEARCH FILTERS
Time filter
Source Type

Jelassi A.,Research Unit of Genetic and Biologic Factors of Atherosclerosis | Najah M.,Research Unit of Genetic and Biologic Factors of Atherosclerosis | Slimani A.,Research Unit of Genetic and Biologic Factors of Atherosclerosis | Jguirim I.,Research Unit of Genetic and Biologic Factors of Atherosclerosis | And 2 more authors.
Current Genomics | Year: 2013

Autosomal dominant hypercholesterolemia (ADH) is characterized by an isolated elevation of plasmatic low-density lipoprotein (LDL), which predisposes to premature coronary artery disease (CAD) and early death. ADH is largely due to mutations in the low-density lipoprotein receptor gene (LDLR), the apolipoprotein B-100 gene (APOB), or the proprotein convertase subtilisin/kexin type 9 (PCSK9). Early diagnosis and initiation of treatment can modify the disease progression and its outcomes. Therefore, cascade screening protocol with a combination of plasmatic lipid measurements and DNA testing is used to identify relatives of index cases with a clinical diagnosis of ADH. In Tunisia, an attenuated phenotypic expression of ADH was previously reported, indicating that the establishment of a special screening protocol is necessary for this population. © 2013 Bentham Science Publishers.

Loading Research Unit of Genetic and Biologic Factors of Atherosclerosis collaborators
Loading Research Unit of Genetic and Biologic Factors of Atherosclerosis collaborators